Inverse correlation between baseline inhibin B and FSH after stimulation with GnRH: a study of serum levels of inhibin A and B, pro alpha-C and activin A in women with ovulatory disturbances before and after stimulation with GnRH

被引:2
作者
Casper, FW
Seufert, RJ
Pollow, K
机构
[1] Johannes Gutenberg Univ Mainz, Dept Expt Endocrinol, D-55101 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, D-55101 Mainz, Germany
关键词
D O I
10.1530/eje.0.1430077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Interest has focused recently on the influences of the polypeptide factors inhibin and activin on the selective regulation of the pituitary secretion of gonadotropins. Design: Measurement of the concentrations of inhibin-related proteins in relation to the changes in pituitary gonadotropin (FSH, LH) parameters, after GnRH stimulation with a bolus injection of 100 mu g gonadorelin, in 19 women with ovulatory disturbances. Methods: Serum levels of inhibin A and B, activin A, and pro alpha-C were measured using sensitive ELISA kits. Results: Within 60 min after GnRH stimulation, FSH values doubled from 5 to 10 mU/ml (P < 0.001). LH increased 12-fold from 2 to 24 mU/ml (P < 0.001). Activin A showed a significant decrease from 0.47 to 0.36 ng/ml (P < 0.001), whereas pro alpha-C increased from 127 to 156 pg/ml (P = 0.039). The median inhibin A concentration did not show a significant change between baseline and the 60 min value, whereas inhibin B was characterized by a minor, but not significant, increase in the median from 168 to 179 pg/ml (P = 0.408). A significant inverse correlation (P = 0.014) with a mean coefficient of correlation of 0.5516 was found, demonstrating a strong relationship between high inhibin B baseline levels and a small increase of FSH after 60 min. Conclusion: Our results show an interesting correlation between the baseline inhibin B and the change in FSH before and after GnRH stimulation. A high baseline inhibin B implies only a minor increase of FSH after 60 min.
引用
收藏
页码:77 / 84
页数:8
相关论文
共 30 条
[1]   NEURO-ENDOCRINE ABERRATIONS IN WOMEN WITH FUNCTIONAL HYPOTHALAMIC AMENORRHEA [J].
BERGA, SL ;
MORTOLA, JF ;
GIRTON, L ;
SUH, B ;
LAUGHLIN, G ;
PHAM, P ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (02) :301-308
[2]   CHARACTERIZATION AND THE REGULATION OF INHIBIN ACTIVIN SUBUNIT PROTEINS OF CULTURED RAT ANTERIOR-PITUITARY-CELLS [J].
BILEZIKJIAN, LM ;
VAUGHAN, JM ;
VALE, WW .
ENDOCRINOLOGY, 1993, 133 (06) :2545-2553
[3]   Both inhibin A and B respond to exogenous follicle-stimulating hormone in the follicular phase of the human menstrual cycle [J].
Burger, HG ;
Groome, NP ;
Robertson, DM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :4167-4169
[4]  
DODSON WC, 1995, REPROD ENDOCRINOLOGY, P2183
[5]   PURIFICATION AND CHARACTERIZATION OF ERYTHROID-DIFFERENTIATION FACTOR (EDF) ISOLATED FROM HUMAN-LEUKEMIA CELL-LINE THP-1 [J].
ETO, Y ;
TSUJI, T ;
TAKEZAWA, M ;
TAKANO, S ;
YOKOGAWA, Y ;
SHIBAI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (03) :1095-1103
[6]   DETECTION OF DIMERIC INHIBIN THROUGHOUT THE HUMAN MENSTRUAL-CYCLE BY 2-SITE ENZYME-IMMUNOASSAY [J].
GROOME, NP ;
ILLINGWORTH, PJ ;
OBRIEN, M ;
COOKE, I ;
GANESAN, TS ;
BAIRD, DT ;
MCNEILLY, AS .
CLINICAL ENDOCRINOLOGY, 1994, 40 (06) :717-723
[7]   QUANTIFICATION OF INHIBIN PRO-ALPHA-C-CONTAINING FORMS IN HUMAN SERUM BY A NEW ULTRASENSITIVE 2-SITE ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
GROOME, NP ;
ILLINGWORTH, PJ ;
OBRIEN, M ;
PRIDDLE, J ;
WEAVER, K ;
MCNEILLY, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (10) :2926-2932
[8]   Measurement of dimeric inhibin B throughout the human menstrual cycle [J].
Groome, NP ;
Illingworth, PJ ;
OBrien, M ;
Pai, R ;
Rodger, FE ;
Mather, JP ;
McNeilly, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (04) :1401-1405
[9]  
Halvorson LM, 1996, FERTIL STERIL, V65, P459
[10]   Differential control of gonadotropin secretion in the human: endocrine role of inhibin [J].
Hayes, FJ ;
Hall, JE ;
Boepple, PA ;
Crowley, WF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (06) :1835-1841